These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33925348)

  • 1. The Association between Physical Activity and CAMDEX-DS Changes Prior to the Onset of Alzheimer's Disease in Down Syndrome.
    Pape SE; Baksh RA; Startin C; Hamburg S; Hithersay R; Strydom A
    J Clin Med; 2021 Apr; 10(9):. PubMed ID: 33925348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing diagnostic thresholds for Alzheimer's disease in adults with Down syndrome: the Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and Others with Intellectual Disabilities (CAMDEX-DS).
    Beresford-Webb JA; Mak E; Grigorova M; Daffern SJ; Holland AJ; Zaman SH
    BJPsych Open; 2021 Apr; 7(3):e79. PubMed ID: 33845926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrichment Effects on Adult Cognitive Development: Can the Functional Capacity of Older Adults Be Preserved and Enhanced?
    Hertzog C; Kramer AF; Wilson RS; Lindenberger U
    Psychol Sci Public Interest; 2008 Oct; 9(1):1-65. PubMed ID: 26162004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The validity and reliability of the CAMDEX-DS for assessing dementia in adults with Down syndrome in Brazil.
    Fonseca LM; Haddad GG; Mattar GP; Oliveira MC; Simon SS; Guilhoto LM; Busatto GF; Zaman S; Holland AJ; Hoexter MQ; Bottino CM
    Braz J Psychiatry; 2019; 41(3):225-233. PubMed ID: 30365671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adaptation and validation of CAMDEX-DS (Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and others with intellectual disabilities) in Spanish population with intellectual disabilities].
    Esteba-Castillo S; Dalmau-Bueno A; Ribas-Vidal N; Vilà-Alsina M; Novell-Alsina R; García-Alba J
    Rev Neurol; 2013 Oct; 57(8):337-46. PubMed ID: 24081888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modified CAMDEX informant interview is a valid and reliable tool for use in the diagnosis of dementia in adults with Down's syndrome.
    Ball SL; Holland AJ; Huppert FA; Treppner P; Watson P; Hon J
    J Intellect Disabil Res; 2004 Sep; 48(Pt 6):611-20. PubMed ID: 15312062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical exploration of the neural bases of behavioural disinhibition, apathy and executive dysfunction in preclinical Alzheimer's disease in people with Down's syndrome: potential involvement of multiple frontal-subcortical neuronal circuits.
    Ball SL; Holland AJ; Watson PC; Huppert FA
    J Intellect Disabil Res; 2010 Apr; 54(4):320-36. PubMed ID: 20202073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personality and behaviour changes mark the early stages of Alzheimer's disease in adults with Down's syndrome: findings from a prospective population-based study.
    Ball SL; Holland AJ; Hon J; Huppert FA; Treppner P; Watson PC
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):661-73. PubMed ID: 16802281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities.
    Ball SL; Holland AJ; Treppner P; Watson PC; Huppert FA
    Br J Clin Psychol; 2008 Mar; 47(Pt 1):1-29. PubMed ID: 17681112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A German version of the Cambridge examination for mental disorders of older people with Down's syndrome and others with intellectual disabilities : A diagnostic procedure for detecting dementia in people with Down's syndrome].
    Nübling G; Loosli SV; Wlasich E; Prix C; Schönecker S; Freudelsperger L; Smrzka N; Strydom AM; Zaman SH; Benejam B; Missios J; Meister R; Danek A; Levin J
    Z Gerontol Geriatr; 2020 Oct; 53(6):546-551. PubMed ID: 31399752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome.
    Startin CM; Hamburg S; Hithersay R; Davies A; Rodger E; Aggarwal N; Al-Janabi T; Strydom A
    Wellcome Open Res; 2016 Nov; 1():11. PubMed ID: 28018980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between cardiovascular health and cognition in adults with Down syndrome.
    Frank L; Helsel B; Dodd D; Bodde AE; Danon JC; Sherman JR; Forsha DE; Szabo-Reed A; Washburn RA; Donnelly JE; Ptomey LT
    J Neurodev Disord; 2023 Dec; 15(1):43. PubMed ID: 38057709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
    Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
    Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome.
    Startin CM; Lowe B; Hamburg S; Hithersay R; Strydom A;
    Front Psychiatry; 2019; 10():158. PubMed ID: 31057430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease.
    Aschenbrenner AJ; Baksh RA; Benejam B; Beresford-Webb JA; Coppus A; Fortea J; Handen BL; Hartley S; Head E; Jaeger J; Levin J; Loosli SV; Rebillat AS; Sacco S; Schmitt FA; Thurlow KE; Zaman S; Hassenstab J; Strydom A
    Alzheimers Dement (Amst); 2021; 13(1):e12184. PubMed ID: 33969175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trial.
    Cyarto EV; Lautenschlager NT; Desmond PM; Ames D; Szoeke C; Salvado O; Sharman MJ; Ellis KA; Phal PM; Masters CL; Rowe CC; Martins RN; Cox KL
    BMC Psychiatry; 2012 Oct; 12():167. PubMed ID: 23050829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology.
    Margallo-Lana ML; Moore PB; Kay DW; Perry RH; Reid BE; Berney TP; Tyrer SP
    J Intellect Disabil Res; 2007 Jun; 51(Pt. 6):463-77. PubMed ID: 17493029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delaying cognitive and physical decline through multidomain interventions for residents with mild-to-moderate dementia in dementia care units in Taiwan: A prospective cohort study.
    Liang CK; Chou MY; Chen LY; Wang KY; Lin SY; Chen LK; Lin YT; Liu TY; Loh CH
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():36-43. PubMed ID: 28436184
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.